AzTrials
AzTrials

Type2 Diabetes MellitusNCT04440319

Diabetes Nutrition Education With Glycemic Control

A study testing Intervention group in people with Type2 Diabetes Mellitus, run by Andalas University at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

T2DM in Indonesia has increased dramatically from 7.0% in 2017 to 10.9% in 2018. In Padang, West Sumatra, diabetes prevalence was 1.3% in 2013 and increased slowly in 2018. Majority of T2DM were not able to achieve optimal glycaemic glucose control measured using HbA1c with a target of less than < 6.5% based on WHO… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Type2 Diabetes Mellitus
What is being tested?
Intervention group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteIndonesia
Study dates
1 Jul 2020to 31 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • T2DM Patients with new diagnosed at least 6 months
  • Patients with range age 18-65 years old
  • Male and female who can read and write
  • Patients can communicate well

Who cannot join

  • T2DM patients with stroke and complication
  • T2DM patients who are pregnant and breastfeeding women

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Ice Yolanda Puri

    Padang, WEST Sumatera, 25142

Other trials in Indonesia

About this study

Official title: A 12-Week Double-Blind of Diabetes Nutrition Education in T2D

T2DM in Indonesia has increased dramatically from 7.0% in 2017 to 10.9% in 2018. In Padang, West Sumatra, diabetes prevalence was 1.3% in 2013 and increased slowly in 2018. Majority of T2DM were not able to achieve optimal glycaemic glucose control measured using HbA1c with a target of less than < 6.5% based on WHO recommendation.

Problem Statement NCD guidelines provided management DM in general. Pedoman Gizi Seimbang was for healthy people. It is crucial to update the guideline following the current issues even the Indonesian consensus in 2015 provided a T2DM management diet.

Read more

Study Hypotheses There is a significant difference in glycemic control (HbA1c and FBG) nutritional status, knowledge, attitude, practice, quality of life, acceptability and adherence behavior among individuals with T2DM in intervention group.

Procedures Subjects will be divided into Intervention and control groups after they finished reading, signed a letter of agreement and informed consent. Subjects also have the right to be withdrawn after listening explanation of the investigators to seeking the potential participants based on inclusion criteria.

The individual with T2DM (intervention group) will follow the Diabetes Mellitus Nutrition Education (DNE) program based on the curriculum of DNE modules properly and certain measurements. There is a selected nutritionist at each PHC who will convey the DNE program. DM nutrition education counseling will be delivered every week for 30 minutes.

Individual with T2DM

  • Baseline An individual with T2DM will be asked to fill the questionnaire and follow all of the measurements (Nutritional Status, Biochemical, Clinical, and Dietary Intake).
  • Intervention (3 months) All of the subjects will follow the DM Nutrition Education program for 3 months which will be delivered by nutritionists in PHC.
  • Follow up (3 months) All of the subjects will continue the program independently in 3 months. Then, the subjects will do the same activity as a baseline to compare the data between baselines, intervention and follow up Control The individual with T2DM in the control group will still follow the conventional DM nutrition education. After the DNE program finished, the material will also be distributed to the individual with T2DM in the control group.
Read the detailed description

Phase I: Needs Assessment Research Design This is a descriptive statistics study and the aims are to determine the current practice of managing diabetes mellitus among nutritionists. The need for having DM nutrition education among individual with T2DM will be conducted following Cross-sectional study.

Subjects The need assessment will be conducted among all nutritionists at all PHC and individual with T2DM at selected PHC at Padang city.

Sampling The nutritionists will be recruited at all of PHC in Padang City and there are 50 nutritionists. PHC will be recruited using multiple random sampling among districts. Then, individual with T2DM will be selected using simple random sampling among selected PHC. One PHC will be selected at each district. Regarding sample size calculation use HbA1c Standard Deviation, the subjects can be gained, are 158. Therefore, 158 subjects are divided into 11 Districts. There are 12 T2DM patients that will be selected each selected PHC in every district using Random Block. Subjects will be selected following visiting individual with T2DM at PHC.

The study will be conducted at all Public Health Center (PHC) in Padang City. An individual with T2DM will be selected based on inclusion and exclusion criteria, multiply random sampling following a city (Padang), simple random sampling in every district and PHC. One PHC will be selected in every district following the highest number of T2DM patients in each district.

Statistical Analysis Descriptive statistics will be used to examine socio-demographic and current management among nutritionists. The need DM nutrition education among individual with T2DM data, the mean and Standard Deviation (SD) will be calculated for normally distributed continuous variables and frequency (f) and percentage (%) for nominal variables. Pearson's chi-square test will be used to examine independent variables.

Data Collection A Google form questionnaire will be developed and be done pre-test among nutritionists perspective. Pre-test questionnaires will be start at PHC outside Padang. Subjects will be taken 10 nutritionists at selected PHC. The items are Socio-demographic characteristics, Management of diabetes at PHC, Nutritional status measurement, DM education tools, current practice management T2DM, the need DM nutrition education, and DM of knowledge-attitude-practice level. The questionnaire will be distributed to all nutritionists using media social (what application). Data will be key in using the latest SPSS version.

A set questionnaire will be developed among individual with T2DM perspective to determine the need DM nutrition education at PHC. The questionnaire will be tested (pre-test) following selected subjects (10%) at a selected PHC in Padang. A selected PHC is different with 11 PHC that had been selected as simple random sampling accordingly.

Phase II: Development and Assessment Module

The module should be assessed following five expert panel review. Five expert panel reviews will assess the module using a set questionnaire.

The validity is to assess how well the idea of a theoretical construct is represented in a questionnaire. A good module should be analysed regarding the reliability and validity process that is a crucial part of a quantitative research inquiry. Therefore, the result can be studied on construct validity.

Face validity refers to researchers' subjective assessments of the presentation and relevance of the measuring instrument as to whether the items in the instrument appear to be relevant, reasonable, unambiguous and clear.

Content validity refers to whether the content of the questions or items measured in the instrument is representative and adequate when attempting to measure phenomena.

Construct validity is an important part of content validity which provides evidence of the degree of aspects and covariance. Hence, it can be representative of the targeted construct module.

The developing module will be continued with the assessment of the module. Actually, there were no decisions for the number maximum of expert panel review, however, at least five Experts panel will be evaluated and assessed the module. Expert panel reviews are Indonesian nutritionists, dietitians, researchers who are experts in nutrition.

To determine the content domain, the qualitative research method used a semi-structured in-depth interview with five expert panel reviews. The module should have content five items; module should reach population target, module content should be implemented precisely, the module should be delivered at the right time, the module should enhance behavior T2DM patients, and module content should alter T2DM patients self-concept in DM.

Following a validated questionnaire of Sidek Mohd and Jamaludin Ahmad in module content, the experts will determine the level of content DM nutrition education module. The range of scale for this assessment is from 1 (Extremely Agree) to 5 (Extremely Disagree).

A set DM nutrition education module curriculum module will be prepared to deliver the materials to the patients. The DM nutrition education will be developed based on Nutritionists and T2DM perspective on need assessment phase. DM nutrition education module was assessed among expert panel reviews. After that, the materials DM nutrition education module will be delivered by introducing DM, symptom, ethology, CHO counting and exchange, food recommendation, cooking method, reading food labeling, and exercise.

The curriculum will be conveyed in the class twice a month for 60 minutes. There will be materials that patients can bring at home and be practiced as a guideline.

The study is divided into intervention and control groups. After intervention finished, the material will also be distributed to T2DM patients in the control group. Furthermore, they will have the same knowledge after the Nutrition Education program finished. Actually, no differences module which will be delivered among groups. However, the timing to distribute the module should be considered to avoid the effect of a contaminant between groups.

The module will be prepared based on the result from a needs assessment in Phase I. Besides that, materials will follow Indonesian consensus, and guidelines, books that were released from the Indonesian Ministry of Health. The module should follow the management standard of the Indonesian Ministry of Health.

Phase III : Treatment and Evaluation Research Design This is a cluster Randomized Controlled Trial study. Implementation of module is to compare and determine effectiveness Nutrition Education Module diabetes mellitus between intervention and control groups. Data collection will be started from June 2020 to August 2020.

Sampling The clusters will be recruited by Puskesmas (PHC) and random by district will be selected following simple random sampling. Districts are selected based on the highest number of T2DM patients. Therefore, there are four clusters in each group and there are two districts each groups. The districts in intervention group are Kuranji and Pauh and the control group are Padang Selatan and Padang Utara. PHC (clusters) in the intervention group are Kuranji, Belimbing, Ambacang, and Pauh. PHC in the control group are Seberang Padang, Rawang Barat, Alai, and Air Tawar.

Sample Size Number of sample of each arm using 2 groups means comparison is n1 = 36, number of cluster, size (m) is m=4, number of sample size per cluster is n2 = 41 and Total sample is n2 = 75. Using α=0.05, power = 80%, ICC =0.05, total sample are 150 with 75 subject per arms.

Data will be collected using questionnaire with 5 sections. They are Section A: Socioeconomic and Demographic Data, Section B: Glycaemic control, Section C: Nutritional Status, Lipid Profile, and Blood Pressure, Section D: Knowledge, Attitude, Practice, and Section E: Quality of Life.

Individual with T2DM (intervention group) will follow Diabetes Mellitus Nutrition Education (DNE) program based on the curriculum of DNE modules properly and certain measurements. There is a selected nutritionists at each PHC who will convey the DNE program. DM nutrition education counselling will be delivered every week for 30 minutes. Before the DNE is started, selected nutritionists will be introduced of DNE program and curriculum to avoid misunderstanding during the program running.

In order to avoid contamination among groups, nutritionists (intervention group) will be asked to fill in the inform consent and be informed to not show the DM Nutrition Education Module and tool kits to subjects in the control group.

Individual with T2DM in control group will still follow the convention DM nutrition education. After DNE program finished, the material will also be distributed to individual with T2DM in the control group. Furthermore, they will have the same knowledge when the program finished. Actually, there is no differences module which will be distributed among groups. However, the timing to distribute the module should be considered to avoid the contaminant between groups

Data Analysis Statistical analyses will be performed using the latest version of STATA. The data will be checked for normality. Missing treatment intervention data for 3 months (three) and follow up 3 (three) months using an Intention-to-treat (ITT) will be implemented. Baseline data are missing when a mean imputation procedure is done.

Descriptive statistics will be expressed as portions, mean (SD). Time trend for treatment effect will be estimated from General Linear Model (GLM). GLM is to determine the between-group difference at 3 months intervention and 3 months follow up.

Differences between baseline, treatment 3 (three) months and 3 (three) months follow up will be calculated for each outcome. Estimation within and between intervention and control groups will be tested using two way-ANOVA. Sociodemographic characteristic data will be expressed as proportions, mean and Standard Deviation (SD).

One-way repeated measured ANOVA is to test independent variable and a continuous (interval or ratio) dependent variable (within groups). Then, two-way repeated measured ANOVA to test independent variable and dependent variable between groups. However, if the relationship between the covariate and the dependent variable is not linear, ANCOVA is inappropriate.

Being tested
Intervention group
Keywords
DNE mddule, Glycemic control, Diabetes
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention groupBehavioural

    Intervention group is individual with T2DM who will receive DM Nutrition education for 3 months. There are 75 subjects in Intervention group at 2 districts and 4 Public Health Care (PHC).

Study groups in NCT04440319
Study groupRoleWhat they receive
Intervention groups (4 PHC/clinics)ExperimentalIntervention group are individual with T2DM who will receive DM nutrition counseling at selected Public Health Care (PHC). There are 75 subjects in Intervention group at selected 2 districts by randomly and 4 PHC which is selected based on cluster. DM nutrition counseling will be delivered by a selected nutritionist at each PHC. Nutritionist will educate the subjects following DM nutrition education module properly. DM nutrition education will be delivered for 3 months and 30 minutes for each meeting.
Receives: Behavioral: Intervention group
Control groups (4 PHC/clinics)ExperimentalAs the same with intervention group, the control group will have 75 subjects but at the different districts and PHC to avoid contaminant. Control group will follow conventional DM nutrition education. Therefore, there is a selected nutritionists will deliver DM counseling at each PHC.
Receives: Behavioral: Intervention group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HbA1c and Fasting blood glucose

    HbA1c will be analyzed using high performance liquid chromatography, D-10. 158 subjects will be asked to fasting before fasting blood glucose measurement, which will be undertaken by trained clinical staff.

    Measured: 3 months

  2. Statistical analyses for HbA1c and Fasting blood glucose

    Statistical analyses will be performed using the latest version of STATA. The data will be checked for normality. Descriptive statistics will be expressed as portions, mean (SD). The time trend for the treatment effect will be estimated from the General Linear Model (GLM). GLM is to determine the between-group difference at 3 months intervention. Differences between baseline, treatment 3 (three) months will be calculated for each outcome. Estimation within and between intervention and control groups will be tested using two way-ANOVA. Sociodemographic characteristic data will be expressed as proportions, mean and Standard Deviation (SD). One-way repeated measured ANOVA is to test the independent variable and a continuous (interval or ratio) dependent variable (within groups). Then, two-way repeated measured ANOVA to test the independent variable and dependent variable between groups.

    Measured: 3 months

Secondary outcomes (10)
  1. Blood Pressure

    Blood pressure (mm Hg) will be measured following Indonesian consensus 2015. They divides into Systolic < 140mmHg and Diastolic <90mmHg.

    Measured: 3 months

  2. Statistical analyses for Blood Pressure

    Statistical analyses will be performed using the latest version of STATA. The data will be checked for normality. Descriptive statistics will be expressed as portions, mean (SD). The time trend for the treatment effect will be estimated from the General Linear Model (GLM). GLM is to determine the between-group difference at 3 months intervention. Differences between baseline, treatment 3 (three) months will be calculated for each outcome. Estimation within and between intervention and control groups will be tested using two way-ANOVA. Sociodemographic characteristic data will be expressed as proportions, mean and Standard Deviation (SD). One-way repeated measured ANOVA is to test the independent variable and a continuous (interval or ratio) dependent variable (within groups). Then, two-way repeated measured ANOVA to test the independent variable and dependent variable between groups

    Measured: 3 months

  3. Body Mass Index (BMI), assessed by Seca-Tanita scale

    BMI (kg/m2) will be measured by Seca - Tanita scale. Indonesian consensus 2015 divides Body Mass Index (BMI) for T2DM become : BMI underweight (<18.5);BMI normal (from 18.5 to 22.9);BMI overweight (≥23.0);BMI with the risk of overweight (23.0- 24.9);Obesity I (25.0 - 29.9);Obesity II (≥30).

    Measured: 3 months

  4. Statistical analyses for Body Mass Index (BMI)

    Statistical analyses will be performed using the latest version of STATA. The data will be checked for normality. Descriptive statistics will be expressed as portions, mean (SD). The time trend for the treatment effect will be estimated from the General Linear Model (GLM). GLM is to determine the between-group difference at 3 months intervention. Differences between baseline, treatment 3 (three) months will be calculated for each outcome. Estimation within and between intervention and control groups will be tested using two way-ANOVA. Sociodemographic characteristic data will be expressed as proportions, mean and Standard Deviation (SD). One-way repeated measured ANOVA is to test the independent variable and a continuous (interval or ratio) dependent variable (within groups). Then, two-way repeated measured ANOVA to test the independent variable and dependent variable between groups.

    Measured: 3 months

  5. Knowledge-Attitude-Practice DM questionnaire

    Knowledge-Attitude-Practice DM questionnaires are adapted from Besher Gharaibeh, Fatema et al and Indonesian Ministry of Health questionnaire. There are 17 knowledge questionnaires, 25 attitude questionnaires, and 7 practices questionnaires.

    Knowledge The knowledge categorical will be divided into high, moderate, and low level. The high score is 14-17, the moderate score is 7-13, and the lowest score is 0-6.

    Attitude The highest score is 43-125, the moderate score is 26-42, and the lowest score is 0-25

    1 = Do not extremely agree 2= Do not agree 3 = Not sure 4 = Agree 5 = extremely agree Practice The practice categorical will be divided into high, moderate, and low level. The high score is 6-7, the moderate score is 3-5, and the lowest score is 0-6.

    Measured: 3 months

  6. Statistical analyses for knowledge-attitude-practice DM

    Statistical analyses will be performed using the latest version of STATA. The data will be checked for normality. Descriptive statistics will be expressed as portions, mean (SD). The time trend for the treatment effect will be estimated from the General Linear Model (GLM). GLM is to determine the between-group difference at 3 months intervention. Differences between baseline, treatment 3 (three) months will be calculated for each outcome. Estimation within and between intervention and control groups will be tested using two way-ANOVA. Sociodemographic characteristic data will be expressed as proportions, mean and Standard Deviation (SD). One-way repeated measured ANOVA is to test the independent variable and a continuous (interval or ratio) dependent variable (within groups). Then, two-way repeated measured ANOVA to test the independent variable and dependent variable between groups.

    Measured: 3 months

  7. Quality of life, assessed by DM Quality of Life questionnaire

    There are 16 quality of life DM question, is adapted from Singh as previous studies, and following Likert scale.

    The highest score is 28-80, the moderate score is 17-27, and the lowest score is 0- 16

    1 = not extremely satisfied 2= not agree satisfied 3 = Not sure 4 = satisfied 5 = extremely satisfied

    Measured: 3 months

  8. Statistical analyses for quality of life

    Statistical analyses will be performed using the latest version of STATA. The data will be checked for normality. Descriptive statistics will be expressed as portions, mean (SD). The time trend for the treatment effect will be estimated from the General Linear Model (GLM). GLM is to determine the between-group difference at 3 months intervention. Differences between baseline, treatment 3 (three) months will be calculated for each outcome. Estimation within and between intervention and control groups will be tested using two way-ANOVA. Sociodemographic characteristic data will be expressed as proportions, mean and Standard Deviation (SD). One-way repeated measured ANOVA is to test the independent variable and a continuous (interval or ratio) dependent variable (within groups). Then, two-way repeated measured ANOVA to test the independent variable and dependent variable between groups.

    Measured: 3 months

  9. Waist Circumference (WC)

    Waist Circumference (WC) is predictor parameter of T2DM. WC for man is ≥94 cm and for woman is Woman ≥ 80 cm.

    Measured: 3 months

  10. Statistical analyses for Waist Circumference

    Statistical analyses will be performed using the latest version of STATA. The data will be checked for normality. Descriptive statistics will be expressed as portions, mean (SD). The time trend for the treatment effect will be estimated from the General Linear Model (GLM). GLM is to determine the between-group difference at 3 months intervention. Differences between baseline, treatment 3 (three) months will be calculated for each outcome. Estimation within and between intervention and control groups will be tested using two way-ANOVA. Sociodemographic characteristic data will be expressed as proportions, mean and Standard Deviation (SD). One-way repeated measured ANOVA is to test the independent variable and a continuous (interval or ratio) dependent variable (within groups). Then, two-way repeated measured ANOVA to test the independent variable and dependent variable between groups.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2020
  2. Study start1 Jul 2020
  3. Primary completion30 Jan 2021
  4. Study completion31 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study has a DM nutrition education module that will be determined to intervention group (individual with T2DM). While control group follow the conventional DM counseling.
Masking
Single blind
Who is masked
Participant
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04440319
Sponsor's protocol ID
Andalas U
Status last verified
Feb 2022
First submitted
1 May 2020
Last updated
16 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The planning are to do data collection in phase 1 among nutritionist and individuals with T2DM perspective. Then, it will be followed with developing module in phase 2, and intervention in phase 3.

Publications

  • Barakatun Nisak MY, Ruzita AT, Norimah AK, Kamaruddin NA. Medical nutrition therapy administered by a dietitian yields favourable diabetes outcomes in individual with type 2 diabetes mellitus. Med J Malaysia. 2013;68(1):18-23.

    PubMed 23466761

Questions about this trial

What is this clinical trial studying?

A study testing Intervention group in people with Type2 Diabetes Mellitus, run by Andalas University at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HbA1c and Fasting blood glucose (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04440319, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in